Codexis Inc (CDXS)
3.46
-0.07
(-1.98%)
USD |
NASDAQ |
May 08, 16:00
3.46
0.00 (0.00%)
After-Hours: 20:00
Codexis Enterprise Value: 191.66M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 191.66M |
| May 06, 2024 | 193.77M |
| May 03, 2024 | 219.17M |
| May 02, 2024 | 178.25M |
| May 01, 2024 | 162.02M |
| April 30, 2024 | 147.91M |
| April 29, 2024 | 157.79M |
| April 26, 2024 | 130.27M |
| April 25, 2024 | 129.56M |
| April 24, 2024 | 140.15M |
| April 23, 2024 | 147.20M |
| April 22, 2024 | 144.38M |
| April 19, 2024 | 142.26M |
| April 18, 2024 | 140.15M |
| April 17, 2024 | 137.32M |
| April 16, 2024 | 135.20M |
| April 15, 2024 | 132.38M |
| April 12, 2024 | 145.08M |
| April 11, 2024 | 162.01M |
| April 10, 2024 | 163.42M |
| April 09, 2024 | 170.48M |
| April 08, 2024 | 169.07M |
| April 05, 2024 | 167.66M |
| April 04, 2024 | 169.07M |
| April 03, 2024 | 178.24M |
| Date | Value |
|---|---|
| April 02, 2024 | 177.53M |
| April 01, 2024 | 188.47M |
| March 31, 2024 | 188.82M |
| March 28, 2024 | 180.24M |
| March 27, 2024 | 181.65M |
| March 26, 2024 | 177.43M |
| March 25, 2024 | 177.43M |
| March 22, 2024 | 177.43M |
| March 21, 2024 | 180.24M |
| March 20, 2024 | 180.24M |
| March 19, 2024 | 164.78M |
| March 18, 2024 | 163.37M |
| March 15, 2024 | 169.00M |
| March 14, 2024 | 159.86M |
| March 13, 2024 | 172.51M |
| March 12, 2024 | 178.84M |
| March 11, 2024 | 188.68M |
| March 08, 2024 | 178.84M |
| March 07, 2024 | 192.20M |
| March 06, 2024 | 190.79M |
| March 05, 2024 | 199.23M |
| March 04, 2024 | 230.51M |
| March 01, 2024 | 258.98M |
| February 29, 2024 | 261.80M |
| February 28, 2024 | 196.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
12.61M
Minimum
Sep 25 2023
2.591B
Maximum
Nov 08 2021
722.10M
Average
670.51M
Median
Jul 15 2020
Enterprise Value Benchmarks
| Avidity Biosciences Inc | 1.430B |
| Taysha Gene Therapies Inc | 360.37M |
| Janux Therapeutics Inc | 2.830B |
| Tango Therapeutics Inc | 500.85M |
| 2seventy bio Inc | 37.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.50M |
| Revenue (Quarterly) | 17.07M |
| Total Expenses (Quarterly) | 28.96M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 71.56% |
| Profit Margin (Quarterly) | -67.39% |
| Earnings Yield | -26.88% |
| Normalized Earnings Yield | -22.54 |